← Leaderboards
Katherine D Ryman
Louisiana State Univ Hsc Shreveport
$5,831,305
Attributed
$5,831,305
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,831,305 · 11
By mechanism
P20$1,468,623 · 4
R01$1,374,432 · 1
R21$1,248,785 · 3
U54$1,140,177 · 2
S10$599,288 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Attenuation”
- Lawrence Corey · Fred Hutchinson Cancer Center$124,686,255
- Stephen Lev Hoffman · Sanaria, Inc.$61,062,195
- Robert M. Grant · J. David Gladstone Institutes$48,731,024
- Jerri Edwards · University Of South Florida$42,327,407
- John C S Breitner · Johns Hopkins University$38,118,097
- Michael W Weiner · Northern California Institute Res &Educ$36,929,917
Research focus
AttenuationAlphavirusVaccinesImmune ResponseVirulentAttenuatedVirusLifeAttenuated Live Virus VaccineVirulenceImmunogenicityMolecularDesignGenomeResponseMutationPathogenVirus PathogenesisInfectionCytokineDendritic CellsBaseBioterrorismEurope
Grant awards (19)
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine$345,396
R01 · FY2014 · AI · contact PI
IVIS Spectrum CT Imaging System in BSL-3 Containment$599,288
S10 · FY2013 · OD · contact PI
Identifying Factors Limiting CHIKV Disease by Global Transcriptional Profiling$469,329
U54 · FY2013 · AI · contact PI
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine$324,673
R01 · FY2013 · AI · contact PI
Identifying Factors Limiting CHIKV Disease by Global Transcriptional Profiling$505,682
U54 · FY2012 · AI · contact PI
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine$345,396
R01 · FY2012 · AI · contact PI
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine$358,967
R01 · FY2011 · AI · contact PI
Elucidating molecular mechanisms of yellow fever virus virulence$224,218
R21 · FY2011 · AI · contact PI
Elucidating molecular mechanisms of yellow fever virus virulence$201,775
R21 · FY2010 · AI · contact PI
Determining Molecular Mechanisms of Chikungunya Virulence and Attenuation$189,938
R21 · FY2010 · AI · contact PI
Determining Molecular Mechanisms of Chikungunya Virulence and Attenuation$239,360
R21 · FY2009 · AI · contact PI
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS$351,559
P20 · FY2008 · RR · contact PI
Rational design & optimization of new live-attenuated vaccines for alphaviral enc$165,166
U54 · FY2008 · AI · contact PI
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS$285,210
P20 · FY2007 · RR · contact PI
Innate immune evasion and/or antagonism by eastern equine encephalitis virus$175,994
R21 · FY2007 · AI · contact PI
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS$285,554
P20 · FY2006 · RR · contact PI
Innate immune evasion and/or antagonism by eastern equine encephalitis virus$217,500
R21 · FY2006 · AI · contact PI
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS$267,328
P20 · FY2005 · RR
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS$278,972
P20 · FY2004 · RR